Expression of mutant TIE2 p. L914F during mouse development causes embryonic lethality and defects in vascular remodeling
Developmental Dynamics · 2026-09 · 255 (9) · 896-914
DOI: 10.1002/dvdy.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Dynamics, online erschienen am 11.10.2025. Verfasst von Lindsay J Bischoff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Receptor, TIE-2, Vascular Remodeling, Vascular Malformations, Embryonic Development. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association-American Stroke Association, American Heart Association.
Abstract (Originalsprache)
Background
Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development. Therefore, we utilized a genetic mouse model that expresses TIE2 p.L914F to determine its phenotypical effects during development.
Results
B6‐Tg(Rosa26‐TIE2 L914F ) EBos ( TIE2 L914F ) mice were generated and then validated for the presence of the transgene. The constitutive endothelial‐specific Tie2‐Cre line was used to activate expression of the mutant gene during early embryonic development. Tie2‐Cre;TIE2 L914F embryos experienced lethality at approximately embryonic day (E)9.5. Three‐dimensional imaging of embryos and yolk sacs revealed impaired vascular remodeling in mutant animals, resulting in malformed vasculature with disorganized, dilated, and non‐functional blood vessels. The abnormal yolk sac vascular phenotype was not associated with total loss of erythroid cells or increased cell proliferation.
Conclusions
The TIE2 L914F mice used in this study represent a novel genetic model of TIE2 p.L914F‐driven vascular disease. This study provides the first experimental evidence that this mutation is incompatible with early prenatal development due to its deleterious effects on the vasculature, illustrating the vital role of balanced TIE2 signaling during vessel development and remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
ORCID-Profile: Elisa Boscolo
Förderung
- NHLBI NIH HHS
- American Heart Association-American Stroke Association
- American Heart Association
- National Heart, Lung, and Blood Institute
Zitieren
APA
Bischoff, L. J., Schrenk, S., Soroko, K., Sherpa, C., Arasu, A., Reynaud, D., & Boscolo, E. (2026). Expression of mutant TIE2 p. L914F during mouse development causes embryonic lethality and defects in vascular remodeling. Developmental Dynamics, 255(9), 896-914. https://doi.org/10.1002/dvdy.70087
Vancouver
Bischoff LJ, Schrenk S, Soroko K, Sherpa C, Arasu A, Reynaud D, et al. Expression of mutant TIE2 p. L914F during mouse development causes embryonic lethality and defects in vascular remodeling. Developmental Dynamics. 2026;255(9):896-914. doi:10.1002/dvdy.70087
BibTeX
@article{Bischoff2026,
author = {Bischoff, Lindsay J and Schrenk, Sandra and Soroko, Kara and Sherpa, Chhiring and Arasu, Ashok and Reynaud, Damien and Boscolo, Elisa},
title = {Expression of mutant TIE2 p. L914F during mouse development causes embryonic lethality and defects in vascular remodeling},
journal = {Developmental Dynamics},
year = {2026},
volume = {255},
number = {9},
pages = {896--914},
doi = {10.1002/dvdy.70087}
}
EUVIMED